Compare GNLX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | INVE |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | United States |
| Employees | 24 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 74.8M |
| IPO Year | 2022 | 1997 |
| Metric | GNLX | INVE |
|---|---|---|
| Price | $2.35 | $3.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $19.75 | $5.50 |
| AVG Volume (30 Days) | ★ 125.3K | 59.9K |
| Earning Date | 03-19-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.47 | ★ 1182.76 |
| EPS | N/A | ★ N/A |
| Revenue | $8,000.00 | ★ $60,219,000.00 |
| Revenue This Year | N/A | $11.25 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.21 |
| 52 Week Low | $1.99 | $2.86 |
| 52 Week High | $8.54 | $4.07 |
| Indicator | GNLX | INVE |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 43.30 |
| Support Level | $2.35 | N/A |
| Resistance Level | $2.86 | $3.69 |
| Average True Range (ATR) | 0.15 | 0.22 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 8.27 | 7.74 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.